Display options
Share it on

World J Clin Cases. 2021 Jun 26;9(18):4866-4872. doi: 10.12998/wjcc.v9.i18.4866.

Adult rhabdomyosarcoma originating in the temporal muscle, invading the skull and meninges: A case report.

World journal of clinical cases

Geng-Huan Wang, He-Ping Shen, Zheng-Min Chu, Jian Shen

Affiliations

  1. Department of Neurosurgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing 314000, Zhejiang Province, China.
  2. Department of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing 314000, Zhejiang Province, China.
  3. Department of Neurosurgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing 314000, Zhejiang Province, China. [email protected].

PMID: 34222460 PMCID: PMC8223841 DOI: 10.12998/wjcc.v9.i18.4866

Abstract

BACKGROUND: Rhabdomyosarcoma (RMS) is a rare malignant tumor of mesenchymal origin that mainly affects children. Spindle cell/sclerosing RMS (SSRMS) is even rarer. It is a new subtype that was added to the World Health Organization disease classification in 2013. To the best of our knowledge, this is the first reported case of adult SSRMS disease classification originating in the temporal muscle.

CASE SUMMARY: SSRMS originating in the temporal muscle of a male adult enlarged rapidly, destroyed the skull, and invaded the meninges. The tumor was completely removed, and the postoperative pathological diagnosis was SSRMS. Postoperative recovery was good and chemotherapy and radiotherapy were given after the operation. Followed up for 3 mo, no tumor recurred.

CONCLUSION: RMS is one of the differential diagnoses for head soft tissue tumors with short-term enlargement and skull infiltration. Preoperative computed tomography or magnetic resonance imaging is necessary for early detection of tumor invasion of the skull and brain tissue.

©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Keywords: Adult; Case report; Dura Mater; Rhabdomyosarcoma; Skull; Temporal Muscle

Conflict of interest statement

Conflict-of-interest statement: The authors have no conflicts of interest to declare.

References

  1. Acta Neuropathol. 1986;72(2):170-7 - PubMed
  2. Cutis. 2011 Apr;87(4):186-8 - PubMed
  3. Pediatr Radiol. 2008 Jun;38(6):617-34 - PubMed
  4. Cancer. 1988 Jan 15;61(2):209-20 - PubMed
  5. ANZ J Surg. 2002 Feb;72(2):114-20 - PubMed
  6. Semin Pediatr Surg. 2016 Oct;25(5):276-283 - PubMed
  7. Int J Clin Exp Pathol. 2015 Feb 01;8(2):2205-7 - PubMed
  8. Clin Otolaryngol Allied Sci. 2004 Feb;29(1):32-7 - PubMed
  9. J Craniofac Surg. 2018 May;29(3):e221-e224 - PubMed
  10. Neurosurgery. 1985 Jul;17(1):101-4 - PubMed
  11. Nat Rev Dis Primers. 2019 Jan 7;5(1):1 - PubMed
  12. Mol Cell. 1997 Dec;1(1):35-45 - PubMed
  13. Cancer. 1978 Jul;42(1):253-8 - PubMed
  14. Clin Radiol. 1998 May;53(5):357-62 - PubMed
  15. Acta Neuropathol. 1985;66(2):98-104 - PubMed
  16. Cancer. 1984 Feb 15;53(4):1016-9 - PubMed
  17. Pediatr Radiol. 2010 Nov;40(11):1723-38; quiz 1855 - PubMed
  18. Curr Probl Cancer. 1978 Mar;2(9):1-36 - PubMed
  19. Cancer. 1983 Jun 15;51(12):2356-61 - PubMed
  20. PLoS One. 2015 Oct 23;10(10):e0140781 - PubMed
  21. Indian J Surg Oncol. 2018 Jun;9(2):187-191 - PubMed
  22. Int J Pediatr Otorhinolaryngol. 1987 Oct;13(3):279-92 - PubMed
  23. Virchows Arch. 2000 Apr;436(4):305-11 - PubMed
  24. Cancer. 1993 Mar 1;71(5):1904-22 - PubMed

Publication Types